Jessica Ueda
Nurse Practitioner · Charleston, WVNPI 1679069090
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 309 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 37 manufacturers reported payments, led by AbbVie at 24.9% of the total. Reporting peaked in 2021 at $1,506 and has fallen 72.3% since, to $417 in 2025. Among nurse practitioner clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 309 payments — averaging $14.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$771
- Lilly USA, LLC$279
- GSK$249
- AstraZeneca$246
- Pfizer$210
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,477100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$4,477 in reported general payments places this provider in the 95th percentile of 649 nurse practitioner providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 50 | $79,808 |
| MounjaroTirzepatide | 33 | $46,289 |
| EliquisApixaban | 32 | $38,525 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $27,779 |
| LinzessLinaclotide | 20 | $26,694 |
| JardianceEmpagliflozin | 16 | $24,861 |
| FarxigaDapagliflozin Propanediol | 20 | $24,685 |
| GemtesaVibegron | 15 | $13,781 |
| XareltoRivaroxaban | 13 | $12,904 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $5,200 |
| SynthroidLevothyroxine Sodium | 22 | $2,971 |
| Vilazodone Hcl | 28 | $2,817 |
| Gabapentin | 188 | $2,357 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 62 | $2,319 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 55 | $2,240 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $771 | $79,80850 claims |
| Lilly USA, LLCMounjaro | $279 | $46,28933 claims |
| PfizerEliquis | $210 | $38,52532 claims |
| AbbVieLinzess, Synthroid | $1,113 | $29,66642 claims |
| GSKTrelegy Ellipta | $249 | $27,77917 claims |
| Boehringer IngelheimJardiance | $142 | $24,86116 claims |
| AstraZenecaFarxiga | $246 | $24,68520 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $30 | $13,78115 claims |
| Johnson & JohnsonXarelto | $34 | $12,90413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 649 nurse practitioner providers in West Virginia.
Other nurse practitioner in Charleston
- Sarah Crandall-FletcherCharleston$11K
- Monica HigginbothamCharleston$5K
- Monica ArmstrongCharleston$4K
- Wendy LeeberCharleston$3K
- Jamie StonerCharleston$3K
- Teresa GoodsonCharleston$3K
- Lindsey DavisCharleston$2K
- Leigh BrooksPrinceton$75K
- Destiny HowardBeckley$35K
- Rachael RigginsBeckley$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.